Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation (J. Exp. Med. (2019) 216, 5 (1230) DOI: 10.1084/jem.20181522)

Susana García-Silva, Alberto Benito-Martín, Sara Sánchez-Redondo, Alberto Hernández-Barranco, Pilar Ximénez-Embún, Laura Nogués, Marina S. Mazariegos, Kay Brinkmann, Ana Amor López, Lisa Meyer, Carlos Rodríguez, Carmen García-Martín, Jasminka Boskovic, Rocío Letón, Cristina Montero, Mercedes Robledo, Laura Santambrogio, Mary Sue Brady, Anna Szumera-Ciećkiewicz, Iwona KalinowskaJohan Skog, Mikkel Noerholm, Javier Muñoz, Pablo L. Ortiz-Romero, Yolanda Ruano, José L. Rodríguez-Peralto, Piotr Rutkowski, Héctor Peinado

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

The authors regret that in the original version of their paper, Laura Santambrogio and Mary Sue Brady were inadvertently omitted from the author list. The corrected author list appears above. All versions of this article have been corrected.

Original languageEnglish (US)
Number of pages1
JournalJournal of Experimental Medicine
Volume216
Issue number5
DOIs
StatePublished - May 1 2019

    Fingerprint

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

García-Silva, S., Benito-Martín, A., Sánchez-Redondo, S., Hernández-Barranco, A., Ximénez-Embún, P., Nogués, L., Mazariegos, M. S., Brinkmann, K., López, A. A., Meyer, L., Rodríguez, C., García-Martín, C., Boskovic, J., Letón, R., Montero, C., Robledo, M., Santambrogio, L., Brady, M. S., Szumera-Ciećkiewicz, A., ... Peinado, H. (2019). Correction: Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation (J. Exp. Med. (2019) 216, 5 (1230) DOI: 10.1084/jem.20181522). Journal of Experimental Medicine, 216(5). https://doi.org/10.1084/jem.2018152204162019c